Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by QuidelOrtho Corporation

QuidelOrtho Announces Appointment of Two Independent Directors to its Board
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Participate in Three Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Report Third Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Announces New R&D Executive Leader
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Participate in Upcoming Investor Conferences
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Report Second Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports First Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho To Report First Quarter 2024 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Announces Changes in Executive Leadership
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho to Participate in the Evercore ISI Conference
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports Third Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
Tickers QDEL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.